top of page
About
Our Company
Our Leadership Team
Science
Our Technology
DNA Methylation
Exosomes
Products
Our Portfolio
Laboratory Developed Tests Services
Eye Care
Clinical Trial Drug Distribution
Health Supplements
Pipeline
Newsroom
Contact
Investors
More
Use tab to navigate through the menu items.
Newsroom
All Posts
Publication
News
An Innovative Customized Biomimetic Hydrogel for Drug Screening Application Potential: Biocompatibility and Cell Invasion Ability
Jan 27, 2022
A Tailored Biomimetic Hydrogel as Potential Bioink to Print a Cell Scaffold for Tissue Engineering Applications: Printability and Cell Viability Evaluation
Jan 17, 2021
The Potential of a Tailored Biomimetic Hydrogel for In Vitro Cell Culture Applications: Characterization and Biocompatibility
Oct 17, 2020
SMAD3 Hypomethylation as a Biomarker for Early Prediction of Colorectal Cancer
Oct 7, 2020
Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction
May 12, 2020
Hypermethylation of BEND5 contributes to cell proliferation andis a prognostic marker of colorectal cancer
Nov 1, 2017
bottom of page
